CD8A and non-small cell lung carcinoma: NSCLC cell-derived exosomal circUSP7 suppresses CD8+ T-cell function by upregulating SHP2 expression by sponging miR-934, thereby promoting the resistance of NSCLC patients to anti-PD1 immunotherapy [105].